The role of Mitochondria in ischemic heart disease

Journal of Cardiovascular Pharmacology

Volumn 28, Issue SUPPL. 1, 1996, Pages

  Ferrari, Roberto ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Calcium; Mitochondrial DNA damage; Myocardial ischemia; Myocardial reperfusion; Oxygen free radicals

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; TRIMETAZIDINE;

CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL SURVIVAL; CONFERENCE PAPER; DNA DAMAGE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MITOCHONDRIAL RESPIRATION; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REPERFUSION;

EID: 0029788601     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199606281-00002     Document Type: Conference Paper

References (80)

1. Ferrari R, Visioli O. Calcium channel blockers and ischaemic heart disease: theoretical expectations and clinical experience. Eur Heart J 1991;12:18-24.
2. Lee JA, Allen DG. Mechanisms of acute ischaemic contractile failure of the heart. Role of intracellular calcium. J Clin Invest 1991;88:361-7.
3. Zoratti M, Bernardi P, Di Lisa F. The mitochondria permeability transition pore and its possible role in cell damage under hypoxia. In: Gnalger E, Schneeweis B, Lenz K, eds. Adaptative mechanisms of hypoxia. Vienna: Springer-Verlag, 1996.
4. Gissi Study. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
5. Valente M, Klugman S, Niccoli L, et al. Importance of early recanalization of the occluded coronary artery in acute myocardial infarction for preservation of left ventricular function. J Mol Cell Cardiol 1988;20:145-54.
6. Hearse DJ. Ischemia, reperfusion, and the determinants of tissue injury. Cardiovasc Drugs Ther 1990;4:767-76.
7. Corral-Debrinski M, Shoffner JM, Loti MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992;275:169-80.
8. Mitchell P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Bodminster: Glynn Research, 1966.
9. Gunter TE, Pfeiffer DR. Mechanisms by which mitochondria transport calcium. Am J Physiol 1990;258:C755-86.
10. 2+ in cells and tissues. J Bioenerg Biomembr 1991;23:823-54.
11. Williams AJ, Ferrari R. Methods of studying respiration, ATP synthesis and proton movement in cardiac mitochondria. In: Dhalla NS, ed. Methods in studying cardiac membranes. Boca Raton, FL: CRC Press, 1983:175-86.
12. Ferrari R, Pedersini P, Bongrazio M, et al. Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion. Basic Res Cardiol 1993;88:495-512.
13. Carafoli E. Intracellular calcium homeostasis. Annu Rev Biochem 1987;56:395-433.
14. 2+. Circulation 1992;86:1-35.
15. 2+ revealed by specifically targeted recombinant aequorin. Nature 1992;358:325-7.
16. Wendt-Gallitelli MF, Isenberg G. Total and free myoplasmic calcium during a contraction cycle: X-ray microanalysis in guinea-pig ventricular myocytes. J Physiol (Lond) 1991;435:349-72.
17. Miyata H, Lakatta EG, Stern MD, Silverman HS. Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ Res 1992;71:605-13.
18. 2+ activated hydrophilic channel of the mitochondrial inner membrane by nucleotides. J Membr Biol 1980;54:231-6.
19. Katz AM. Energetics and cardiac failure. Hosp Pract 1991;26:78-90.
20. Guarnieri C, Muscari C. Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats. Biochem Pharmacol 1988;37:4685-8.
21. Dalla Volta S, Maraglino G, Della Valentina P, Viena P, Desideri A. Comparison of trimetazidine with nifedipine in effort angina: a double blind, crossover study. Cardiovasc Drugs Ther 1990;4:853-60.
22. Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P. Trimetazidine: a new concept in the treatment of angina comparison with propranolol in patients with stable angina. Br J Clin Pharmacol 1994;37:279-88.
23. Ferrari R, Curello S, Cargnoni A, et al. Metabolic changes during post-ischemic reperfusion. J Mol Cell Cardiol 1988;20:119-33.
24. 2+ trigger site. Arch Biochem Biophys 1979;195:460-7.
25. 2+-induced membrane transition in mitochondria I. The protective mechanisms. Arch Biochem Biophys 1979;195:453-9.
26. 2+ plus N-ethylmaleimide on mitochondrial function. J Biol Chem 1979;254:11485-94.
27. 2+ movement induced by inorganic phosphate and diamide in rat liver mitochondria. Biochem Biophys Res Commun 1979;88:388-94.
28. Broekcmcier K, Dempsey ME, Pfeffer DR. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 1989;264:7826-30.
29. Fournier N, Ducent G, Crevat A. Action of cyclosporine on mitochondrial calcium fluxes. J Bioenerg Biomembr 1987;19:297-303.
30. Bernardi P. Modulation of the mitochondrial permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem 1992;267:8834-9.
31. Petronilli V, Szabó I, Zoratti M. The inner mitochondrial membrane contains ion-conducting channels similar to those found in bacteria. FEBS Lett 1989;259:137-43.
32. Szabó I, Zoratti M. The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. J Biol Chem 1991;266:3376-9.
33. Szabó I, Zoratti M. The mitochondrial megachannel is the permeability transition pore. J Bioenerg Biomembr 1992;24:111-7.
34. 2+ overload. Eur J Biochem 1988;178:488-501.
35. 2+ release. Arch Biochem Biophys 1979;195:468-77.
36. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
37. Kinnally KW, Antonenko YN, Sorov DB. Modulation of inner mitochondrial membrane channel activity. J Bioenerg Biomembr 1992;24:99-110.
38. 2+. J Biol Chem 1993;268:1011-6.
39. Sorgato MC, Keller BU, Stuhmer W. Patch-clamping of the inner mitochondrial membrane reveals a voltage dependent ion channel. Nature 1987;330:498-500.
40. Joyal JL, Aprille JR. The ATP/Mg/PI carrier of rat liver mitochondria catalyzes a divalent electroneutral exchange. J Biol Chem 1992;267:19198-203.
41. Meisner H, Klingenberg M. Efflux of adenine nucleotides from rat liver mitochondria. J Biol Chem 1968;243:3631-9.
42. Ferrari R, Di Lisa F, Raddino R; Visioli O. Effects of myocardial calcium overloading during ischaemia and reperfusion on ATP synthesis. In: Godfrain T, Albertini A, Paoletti R, eds. Calcium modulators. Amsterdam: Elsevier Biomedical Press, 1982:99-117.
43. Ferrari R, Di Lisa F, Raddino R, Visioli O. The effects of ruthenium red on mitochondrial function during post-ischaemic reperfusion. J Mol Cell Cardiol 1982;14:737-40.
44. Ferrari R, Williams AJ. The role of mitochondria in myocardial damage occurring on post-ischaemic reperfusion. J Appl Cardiol 1986;1:501-19.
45. Ferrari R, Williams AJ, Nayler WG. The relationship between calcium transport and ADP phosphorylation of cardiac mitochondria. J Mol Cell Cardiol 1979;12:9-11.
46. Williams AJ, Crie JS, Ferrari R. Factors influencing cardiac mitochondrial calcium transport and oxidative phosphorylation. In: Caldarera CM, Harris P, eds. Advances in studies on heart metabolism. Bologna: Clueb, 1982:173-183.
47. Cobbe SM, Poole Wilson PA. The time of onset and severity of acidosis in myocardial ischaemia. J Mol Cell Cardiol 1979;12:745-61.
48. Ferrari R. Calcium antagonists and left ventricular dysfunction. In: Buller N, Henderson AH, Krayenbuhl HP, eds. Left ventricular function in stunned and hibernating myocardium. Amsterdam: Excerpta Medica, 1991:41-55.
49. Di Lisa F, Menabó R, Siliprandi N. L-propyonil-carnitine protection of mitochondria in ischemic rat hearts. Mol Cell Biochem 1989;88:169-73.
50. Hardy DL, Clark JB, Darley-Usmar V, Smith DR, Stone D. Reoxygenation dependent decrease in mitochondrial NADH CoQ reductase (complex I) activity in the hypoxicreoxygenated rat heart. Biochem J 1991;274:133-7.
51. Rouslin W. Protonic inhibition of the mitochondrial oligomycin-sensitive adenosine-5-triphosphate in ischemic and autolyzing cardiac muscle. J Biol Chem 1983;258:9657-61.
52. Ferrari R, Ceconi C, Curello S, et al. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med 1991;91:95-105.
53. Ferrari R, Ceconi C, Curello S, Ghielmi S, Albertini A. Superoxide-dismutase: possible therapeutic use in cardiovascular disease. Pharmacol Res 1989;21:57-65.
54. Ferrari R, Ceconi C, Curello S, et al. Oxygen mediated myocardial damage during ischemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardiol 1985;17:937-45.
55. Ferrari R, Albertini A, Curello S, et al. Myocardial recovery during post-ischemic reperfusion: effects of nifedipine, calcium and magnesium. J Mol Cell Cardiol 1986;18:487-8.
56. Ferrari R, Ceconi C, Curello S, et al. Intracellular effects of myocardial ischaemia and reperfusion: role of calcium and oxygen. Eur Heart J 1986;7:3-12.
57. Ferrari R, Ceconi C, Curello S, et al. Role of oxygen free radicals in ischemic and reperfused myocardium. Am J Clin Nutr 1991;53:215-22.
58. 2+ overload in reperfused ischemic myocardium. Annu Rev Physiol 1990;52:543-59.
59. 2+ in myocytes and perfused hearts: the role of mitochondria. J Mol Cell Cardiol 1989;21:963-73.
60. Ferrari R, Boffa GM, Ceconi C, et al. Effect of D-600 on ischaemic and reperfused rabbit myocardium: relation with timing modality of administration. Basic Res Cardiol 1989;84:606-22.
61. Ferrari R, Visioli O. Protective effects of calcium antagonists against ischaemia and reperfusion damage. Drugs 1991;42:14-27.
62. Nayler WG, Ferrari R, Williams AJ. Protective effect of pretreatment with verapamil, nifedipine and propanolol on mitochondrial function in the ischaemic and reperfused myocardium. Am J Cardiol 1980;46:242-8.
63. Jennings KA, Reimer KA. Lethal myocardial ischaemia injury. Am J Pathol 1981;102:241-55.
64. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 1990;18:6927-33.
65. Ozawa T, Tanaka M, Sugiyama S, et al. Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathy. Biochem Biophys Res Commun 1990;170:830-6.
66. Hattori K, Tanaka M, Sugiyama S, et al. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributor factor in presbycardia. Am Heart J 1991;121:1735-42.
67. Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, Wallace DC. Hypoxemia is associated with mi- tochondrial DNA damage and gene induction: implications for cardiac disease. JAMA 1991;266:1812-6.
68. Wallace DC, Singh G, Lott M, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-30.
69. Miranda DF, Ishii S, DiMauro S, Shay JM. Cytochrome C oxidase (COX) deficiency in Leigh's syndrome: genetic evidence for a nuclear DNA-encoded mutation. Neurology 1989;39:697-702.
70. Rotig A, Colonna M, Blanche S, et al. Mitochondrial DNA deletions in Pearson's marrow/pancreas syndrome. Lancet 1989;1:902-3.
71. lys mutation causes myoclonic epilepsy and ragged red fiber disease. In: Sato T, DoMauro s, eds. Progress in neuropathology. New York: Raven Press, 1991:161-7.
72. Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989;1:642-5.
73. Trounce I, Byrner E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in aging. Lancet 1989;1:637-9.
74. Fleg JL. Alterations in cardiovascular structure and function with advancing age. Am J Cardiol 1986;57:33C-44C.
75. Lakatta EG. Cardiac muscle changes in senescence. Annu Rev Physiol 1987;49:519-31.
76. Ferrari R. The role of free radicals in ischaemic myocardium. Br J Clin Pract 1990;44:301-5.
77. Ferrari R, Alfieri O, Curello S, et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 1990;81:201-11.
78. Ferrari R, Ceconi C, Curello S, et al. Role of oxygen free radicals in ischemic and reperfused myocardium. Am J Clin Nutr 1991;53:215-22.
79. Fukanaga M, Yielding KL. Fate during cell growth of yeast mitochondria and nuclear DNA after photolytic attachment of the monoazide analog of ethidium. Biochem Biophys Res Commun 1979;90:582-6.
80. Katz AM. Cardiomyopathy of overload: a major determinant prognosis in congestive heart failure. N Engl J Med 1990;322:100-10.